Effects of dietary restriction and antioxidants on presbyacusis

Laryngoscope

Volumn 110, Issue 5 I, 2000, Pages 727-738

  Seidman, Michael D ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Anti aging; Antioxidants; Presbyacusis; Reactive oxygen metabolites

Indexed keywords

ANTIOXIDANT; LAZAROID; REACTIVE OXYGEN METABOLITE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY THRESHOLD; BLOOD VESSEL PERMEABILITY; CALORIC RESTRICTION; CELL LOSS; CELL PROTECTION; CONTROLLED STUDY; DIET RESTRICTION; DNA DAMAGE; EVOKED BRAIN STEM RESPONSE; GENE DELETION; MEMBRANE POTENTIAL; NONHUMAN; POLYMERASE CHAIN REACTION; PRESBYACUSIS; PRIORITY JOURNAL; VISCOSITY;

EID: 0034062312     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200005000-00003     Document Type: Article

References (70)

1. Prazma J, Carrasco VN, Butler B, Waters G, Anderson T, Pillsbury HC. Cochlear microcirculation in young and old gerbils. Arch Otolaryngol Head Neck Surg 1990;116(8): 932-936.
2. Seidman MD, Khan MJ, Dolan DF, Quirk WS. Age-related differences in cochlear microcirculation and auditory brain stem response. Arch Otolaryngol Head Neck Surg 1996; 122(11):1221-1226.
3. Gacek MR, Schuknecht HF. Pathology of presbycusis. Int Audiol 1969;8:199-209.
4. Rosenhall U, Pederson K, Dotevall M. Effects of presbycusis and other types of hearing loss on auditory brainstem responses. Scand Audiol 1986;15(4):179-185.
5. Semsei I, Roa G, Richardson A. Changes in the expression of superoxide dismutase and catalase as a function of age and dietary restriction. Biochem Biophys Res Commun 1989; 164(2):620-625.
6. Hattori K, Tanaka M, Sugiyama S, et al. Age-dependent increase in deleted mitochondrial DNA in the human heart: possible contributory factor to presbycardia. Am Heart J 1991;121(6, Part 1):1735-1742.
7. Wallace DC. Diseases of the mitochondrial DNA. Annu Rev Biochem 1992;61:1175-1212.
8. Cortopassi GA, Arnheim N. Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucleic Acids Res 1990;18(23):6927-6933.
9. Johns M, Brackmann DE, Kimmelman C, Papsidero MJ, Koopman CF Jr, Loury M. Goals and mechanisms for training otolaryngologists in the area of geriatric medicine. Otolaryngol Head Neck Surg 1989;100(4):262-265.
10. Gates GA, Caspery DM, Clark W, Pillsbury HC III, Brown SC, Dobie RA. Presbyacusis. Otolaryngol Head Neck Surg 1986;100(4):266-271.
11. Sixt E, Rosenhall U. Presbyacusis related to socioeconomic factors and state of health. Scand Audiol 1997;26(3): 133-140.
12. Halliwell B, Gutteridge JM, Cross CE. Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med 1992;119(6):598-620.
13. Byers T, Bowman B. Vitamin E supplements and coronary heart disease. Nutr Rev 1993;51(11):333-336.
14. Ziegler RG. Vegetables, fruits and carotenoids and the risk of cancer. Am J Clin Nutr 1991;53(Suppl 1):251S-259S.
15. Comstock GW, Helzlsouer KJ, Bush TL. Prediagnostic serum levels of carotenoids and vitamin E as related to subsequent cancer in Washington County, Maryland. Am J Clin Nutr 1991;53(Suppl 1):260S-264S.
16. Smith MA, Perry G. Free radical damage, iron and Alzheimer's disease. J Neural Sci 1995;134(Suppl):92-94.
17. Jenner P, Olanow CW. Oxidative stress and the pathogenesis of Parkinson's disease. Neurol 1996;47(6 [Suppl 3]): S161-S170.
18. Johnsson LG, Hawkins JE Jr. Vascular changes in the human inner ear associated with aging. Ann Otol Rhinol Laryngol 1972;81(3):364-376.
19. Prazma J, Butler B, Waters G, Anderson TL, Pillsbury HC. Proceedings of the 71st Annual Meeting of the Federation of American Societies for Experimental Biology [abstract 1538]. Washington, DC. March 29-April 2, 1987;46(4): 1538.
20. Gatehouse S, Lowe GD. Whole blood viscosity and red cell filterability as factors in sensorineural hearing impairment in the elderly. Acta Otolaryngol Suppl (Stockh) 1990; 476:37-43.
21. Axelsson A. The cochlear blood vessels in guinea pigs of different ages. Acta Otolaryngol (Stockh) 1971;72(3): 172-181.
22. Wing KG. Studies of basic cochlear physiology and the energy metabolism of the cochlear response in the rat. Acta Otolaryngol Suppl (Stockh) 1959;148:1-97.
23. Fernandez C, Alzate R. Modifications of cochlear responses to oxygen deprivation. Arch Otolaryngol 1959;69(1):82-94.
24. Kimura R, Perlman HB. Experimental obstruction of the venous drainage and arterial supply of the inner ear. Ann Otol Rhinol Laryngol 1956;65(2):332-350.
25. Honrubia V, Johnston BM, Butler RA. Maintenance of cochlear potentials during asphyxia. Acta Otolaryngol (Stockh) 1965;60:105-112.
26. Woolf NK, Ryan AF, Harris JP. Development of mammalian endocochlear potential: normal ontogeny and effects of anoxia. Am J Physiol 1986;250:493-498.
27. Demopuolos HB, Flamm ES, Pietronigro DD, Seligman ML. The free radical pathology and the microcirculation in the major central nervous system disorders. Acta Physiol Scand Suppl 1980;492:91-119.
28. Raichle ME. The pathophysiology of brain ischemia. Ann Neurol 1983;13(1):2-10.
29. Wallace DC, Zheng XX, Lott MT, et al. Familial mitochondrial encephalopathy (MERFF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell 1988;55(4):601-610.
30. Ernster L, Ikkos D, Luft R. Enzyme activities of human skeletal muscle mitochondria: a tool in clinical metabolic research. Nature 1959;184:1851-1854.
31. Luft R, Ikkos D, Palmieri G, Ernster L, Afzelius B. A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study. J Clin Invest 1962;41:1776-1804.
32. Shoffner JM, Lott MT, Voljavec AS, et al. Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy. Proc Natl Acad Sci U S A 1989;86(20):7952-7956.
33. Pavlakis SG, Phillips PC, DiMauro S, DeVivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 1984;16(4):481-488.
34. DiMauro S, Bonilla E, Lombes A, Shanske S, Minetti C, Moraes CT. Mitochondrial encephalomyopathies. Neurol Clin 1990;8(3):483-506.
35. Gold M, Rapin I, Shanske S. Mitochondrial inheritance of acquired deafness. Ann N Y Acad Sci 1991;630:301-302.
36. Corral-Debrinski M, Stepien G, Shoffner JM, et al. Hypoxemia is associated with mitochondrial DNA damage and gene induction: implications for cardiac disease. JAMA 1991;266(13):1812-1816.
37. Merril CR, Zullo S, Ghanbari H, et al. Possible relationship between conditions associated with chronic hypoxia and brain mitochondrial DNA deletions. Arch Biochem Biophys 1996;326(1):172-177.
38. Trounce I, Byrne E, Marzuki S. Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in aging [comments]. Lancet 1989;1(8639):637-639.
39. Nohl H, Hegner D. Do mitochondria produce oxygen radicals in vivo? Eur J Biochem 1978;82(2):563-567.
40. Bandy B, Davison AJ. Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging? Free Radical Biol Med 1990;8(6):523-539.
41. Piko L, Houghman AJ, Bulpitt KJ. Studies of sequence heterogeneity of mitochondrial DNA from rat and mouse tissues: evidence for an increased frequency of deletions/ additions with aging. Mech Ageing Dev 1988;43(3): 279-293.
42. Miyabayashi S, Hanamizu H, Endo H, Tada K, Horai S. A new type of mitochondrial DNA deletion in patients with encephalomyopathy. J Inherit Metab Dis 1991;14(5): 805-812.
43. Ballinger SW, Shoffner JM, Hedaya EV, et al. Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nat Genet 1992;1(1): 11-15.
44. van den Ouweland JM, Lemkes HH, Ruitenbeek W, Sandkuijl LA. Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1992;1(5): 368-371.
45. Sawada S, Takeda T, Kakigi A, et al. Audiological findings of sensorineural deafness associated with a mutation in the mitochondrial DNA. Am J Otol 1997;18:332-335.
46. Ueda N, Oshima T, Ikeda K, Takasaka T. Mitochondrial DNA mutations and presbycusis. Presented at the Molecular Biology of Hearing and Deafness meeting. Bethesda, MD, October 6-8, 1995.
47. Bai U, Seidman MD, Hinojosa R, Quirk WS. Mitochondrial DNA deletions associated with aging and possibly presbyacusis: a human archival temporal bone study. Am J Otol 1997;18:449-453.
48. Pommier JP, Lebeau J, Ducray C, et al. Chromosomal instability and alteration of telomere repeat sequences. Biochimie 1995;77(10):817-825.
49. Hockenberry DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993;75(2):241-252.
50. Kane DJ, Sarafian TA, Anton R, et al. Bcl-2 inhibition of neural cell death: decreased generation of reactive oxygen species. Science 1993;262(5137):1274-1277.
51. Sohal RS, Allen RG. Relationship between metabolic rate, free radicals, differentiation and aging: a unified theory. Basic Life Sci 1985;35:75-104.
52. Southern PA, Powis G. Free radicals in medicine, I: chemical nature and biologic reactions. Mayo Clin Proc 1988;63(4): 381-389.
53. Zs-Nagy I, Semsei I. Centrophenoxine increases the rates of total and mRNA synthesis in the brain cortex of old rats: an explanation of its action in terms of the membrane hypothesis of aging. Exp Gerontol 1984;19(3):171-178.
54. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74(4):609-619.
55. Trounce IA, Kim YL, Jun AS, Wallace DC. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol 1996;264:484-509.
56. Ernster L, Nordenbrand K. Skeletal muscle mitochondria. Methods Enzymol 1967;10:86-94.
57. McCabe PC. A Guide to Methods and Applications in PCR Protocols. New York: Academic Press, 1990:76-83.
58. SAS Institute, Inc. SAS/STAT Software: Changes and Enhancements Through Release 6.11. Cary, NC: SAS Institute, Inc., 1996:31-656.
59. Gratton MA, Schulte BA. Alterations in microvasculature are associated with atrophy of the stria vascularis in quiet-aged gerbils. Hear Res 1995;82(1):44-52.
60. Pujol R, Guy R, Fuel J, Lenoir M, Eybalin M, Recasens M. Glutamate neurotoxicity in the cochlea: a possible consequence of ischaemic or anoxic conditions occurring in aging. Acta Otolaryngol Suppl (Stockh) 1990;476:32-36.
61. Seidman MD, Quirk WS, Nuttall AL, Schweitzer VG. The protective effects of allopurinol and SOD-PEG on ischemic induced cochlear damage. Otolaryngol Head Neck Surg 1991;105(3):457-463.
62. Bolli R. Superoxide dismutase 10 years later: a drug in search of a use. J Am Coll Cardiol 1991;18(1):231-233.
63. Young B, Runge JW, Waxman KS, et al. Effects of pegorgotein on neurologic outcome of patients with severe head injury. JAMA 1996;276(7):538-543.
64. Riemersma RA, Wood DA, Macintyre CC, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamin A, C, and E, and carotene. Lancet 1991; 337(8732):1-5.
65. Tolmasoff JM, Ono T, Cutler RG. Superoxide dismutase: correlation with life-span and specific metabolic rate in primate species. Proc Natl Acad Sci USA 1980;77(5): 2777-2781.
66. Harman D. Free radical theory of aging: effect of free radical reaction inhibitors on the mortality rate of male LAF mice. J Gerontol 1968;23(4):476-482.
67. Heidrick ML, Hendricks LC, Cook DE. Effect of dietary 2-mercaptoethanol on the life span, immune system, tumor incidence and lipid peroxidation damage in spleen lymphocytes of aging BC3F1 mice. Mech Ageing Dev 1984;27(3): 341-358.
68. Cutler RG. Redundancy of information content in the genome of mammalian species as a protective mechanism determining aging rate. Mech Ageing Dev 1973;2(6):381-408.
69. Sacher. Longevity in vertebrates: a further comment. Fed Proc 1976;35:1112-1113.
70. Chen H, Tappel AL. Protection of vitamin E, selenium, Trolox C, ascorbic acid palmitate, acetylcysteine, coenzyme Q-0, coenzyme Q-10, beta carotene, canthaxanthin, and (+)-catechin against oxidative damage to rat blood and tissues in vivo. Free Rad Biol Med 1995;18(5):949-953.